Phase 1/1b Dose Escalation Study Evaluating BSI-201 as a Single Agent and in Combination With Irinotecan in Subjects With Advanced Solid Tumors
Clinical trial NCT00298675 · COMPLETED
Trial details
- NCT number
- NCT00298675
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2010-07-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.